$LLY · Eli Lilly and Company

Eli Lilly and Company filed a Form 8-K on October 29, 2026, reporting under Item 2.02 that it had issued a press release announcing its financial results for the quarter ended September 30, 2026. The press release is attached as Exhibit 99.1. The filing states that this information is being furnished and is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, and it will not be incorporated by reference into other filings except as expressly stated.

The report also identifies the company’s registered securities, including common stock and several series of notes listed on the New York Stock Exchange, and was signed by Donald A. Zakrowski, Senior Vice President, Finance and Chief Accounting Officer. The extracted filing text does not include the actual financial figures from the press release.